Lulibest 1% Cream contains luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum activity against dermatophytes, yeasts, and molds by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation facilitates effective penetration into the stratum corneum, ensuring targeted antifungal action at the site of infection. Lulibest 1% Cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis caused by susceptible strains of Trichophyton, Microsporum, and Epidermophyton species. The recommended application involves a thin layer applied once daily to the affected area and surrounding skin, typically for a duration of 2 to 4 weeks depending on the clinical response. Luliconazole is generally well tolerated; adverse effects are infrequent and may include mild local irritation, erythema, or itching at the application site. Contraindications include hypersensitivity to luliconazole or any cream excipients. Lulibest 1% Cream should be used under medical supervision, with adherence to prescribed treatment duration to prevent recurrence and resistance development.